At the time of signing, $104 million in funding was obligated under the agreement. According to the supplied information, all of the initial funding comes from export partners that are co-financing the development through the Foreign Military Sales process.
The AIM-120 AMRAAM is currently produced in the C-8 and D-3 variants. It is the main medium-range weapon for 14 multirole combat aircraft platforms of American, European and Asian production.
More than 6,000 AIM-120 AMRAAM missiles have been fired during testing and combat operations. The main current area of combat use is Ukraine, where the missiles are used with F-16AM/BM Fighting Falcon aircraft and the NASAMS system.
The agreement supports the next phase of AMRAAM development while relying on export partner funding through FMS. It also continues work on future missile variants intended to sustain the weapon’s role across allied air combat and air defence systems.
